Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Revvity Inc
13G/A
Amendment 2
RVTY · 714046109
|
4.9% |
5/14/2025
Event 3/31/2025
|
|||
|
Icu Medical, Inc.
13G/A
Amendment 10
ICUI · 44930G107
|
10.0% |
5/7/2025
Event 4/30/2025
|
|||
| Janus Henderson Group PLC | 10.0% | ||||
| Janus Henderson Enterprise Fund | 5.0% | ||||
|
Mirum Pharamaceuticals, Inc.
13G/A
Amendment 3
MIRM · 604749101
|
10.1% |
5/7/2025
Event 4/30/2025
|
|||
|
Vaxcyte, Inc.
13G/A
Amendment 6
PCVX · 92243G108
|
11.3% |
5/7/2025
Event 4/30/2025
|
|||
|
Bright Minds Biosciences Inc.
13G/A
Amendment 1
DRUG · 10919W405
|
16.0% |
4/7/2025
Event 3/31/2025
|
|||
| Janus Henderson Group PLC | 16.0% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 14.2% | ||||
|
Protara Therapeutics, Inc.
13G/A
Amendment 1
TARA · 74365U107
|
10.3% |
3/7/2025
Event 2/28/2025
|
|||
| Janus Henderson Group PLC | 10.3% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 9.1% | ||||
|
Consensus Cloud Solutions, Inc.
13G/A
Amendment 4
CCSI · 20848V105
|
12.7% |
2/14/2025
Event 12/31/2024
|
|||
| Janus Henderson Group PLC | 12.7% | ||||
| Janus Henderson Triton Fund | 7.3% | ||||
|
Akero Therapeutics Inc
13G/A
Amendment 8
AKRO · 00973Y108
|
8.7% |
2/14/2025
Event 12/31/2024
|
|||
|
Ardelyx Inc
13G/A
Amendment 5
ARDX · 039697107
|
10.3% |
2/14/2025
Event 12/31/2024
|
|||
|
Tenax Therapeutics, Inc
13G/A
Amendment 2
TENX · 88032L605
|
5.4% |
2/14/2025
Event 12/31/2024
|
|||
|
Benitec Biopharma Inc.
13G/A
Amendment 6
BNTC · 08205P209
|
11.3% |
2/14/2025
Event 12/31/2024
|
|||
| Janus Henderson Group PLC | 11.3% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 8.6% | ||||
|
Revvity Inc
13G/A
Amendment 1
RVTY · 714046109
|
5.2% |
2/14/2025
Event 12/31/2024
|
|||
|
Sensient Technologies Corporation
13G/A
Amendment 9
SXT · 81725T100
|
5.3% |
2/14/2025
Event 12/31/2024
|
|||
|
Rentokil Initial plc
13G/A
Amendment 1
RKLIF · G7494G105
|
5.3% |
2/14/2025
Event 12/31/2024
|
|||
|
Ligand Pharmaceuticals Incorporated
13G/A
Amendment 6
LGND · 53220K504
|
5.4% |
2/14/2025
Event 12/31/2024
|
|||
|
Walker & Dunlop, Inc.
13G/A
Amendment 5
WD · 93148P102
|
5.5% |
2/14/2025
Event 12/31/2024
|
|||
|
Immunome Inc
13G/A
Amendment 1
IMNM · 45257U108
|
5.5% |
2/14/2025
Event 12/31/2024
|
|||
|
Blackbaud, Inc.
13G/A
Amendment 8
BLKB · 09227Q100
|
5.7% |
2/14/2025
Event 12/31/2024
|
|||
|
Globus Medical, Inc.
13G/A
Amendment 6
GMED · 379577208
|
5.8% |
2/14/2025
Event 12/31/2024
|
|||
|
Amdocs Limited
13G/A
Amendment 8
DOX · G02602103
|
5.8% |
2/14/2025
Event 12/31/2024
|
|||
|
Zai Lab Ltd
13G/A
Amendment 1
G9887T116
|
6.1% |
2/14/2025
Event 12/31/2024
|
|||
|
Aramark
13G/A
Amendment 1
ARMK · 03852U106
|
6.1% |
2/14/2025
Event 12/31/2024
|
|||
|
CARGO Therapeutics, Inc.
13G/A
Amendment 2
CRGX · 14179K101
|
6.2% |
2/14/2025
Event 12/31/2024
|
|||
|
Asure Software Inc
13G/A
Amendment 1
ASUR · 04649U102
|
6.5% |
2/14/2025
Event 12/31/2024
|
|||
| Janus Henderson Group PLC | 6.5% | ||||
| Janus Henderson Venture Fund | 6.1% | ||||
|
Sensata Technologies Holding PLC
13G/A
Amendment 8
ST · G8060N102
|
6.5% |
2/14/2025
Event 12/31/2024
|
|||
|
SS&C Technologies Holdings, Inc.
13G/A
Amendment 9
SSNC · 78467J100
|
6.7% |
2/14/2025
Event 12/31/2024
|
|||
|
IDEAYA Biosciences, Inc.
13G/A
Amendment 2
IDYA · 45166A102
|
6.8% |
2/14/2025
Event 12/31/2024
|
|||
|
Flex Ltd.
13G/A
Amendment 3
FLEX · Y2573F102
|
6.8% |
2/14/2025
Event 12/31/2024
|
|||
|
Biohaven Ltd.
13G/A
Amendment 3
BHVN · G1110E107
|
6.9% |
2/14/2025
Event 12/31/2024
|
|||
|
Dyne Therapeutics Inc
13G/A
Amendment 1
DYN · 26818M108
|
7.3% |
2/14/2025
Event 12/31/2024
|
|||
|
Structure Therapeutics Inc
13G/A
Amendment 1
GPCR · 86366E106
|
7.3% |
2/14/2025
Event 12/31/2024
|
|||
|
Osi Systems, Inc.
13G/A
Amendment 9
OSIS · 671044105
|
7.4% |
2/14/2025
Event 12/31/2024
|
|||
|
Ziff Davis, Inc.
13G/A
Amendment 4
ZD · 48123V102
|
8.2% |
2/14/2025
Event 12/31/2024
|
|||
|
Vaxcyte, Inc.
13G/A
Amendment 5
PCVX · 92243G108
|
8.5% |
2/14/2025
Event 12/31/2024
|
|||
|
Lantheus Holdings, Inc.
13G/A
Amendment 2
LNTH · 516544103
|
8.9% |
2/14/2025
Event 12/31/2024
|
|||
|
Mirum Pharmaceuticals, Inc.
13G/A
Amendment 2
MIRM · 604749101
|
9.5% |
2/14/2025
Event 12/31/2024
|
|||
|
Icu Medical, Inc.
13G/A
Amendment 9
ICUI · 44930G107
|
9.9% |
2/14/2025
Event 12/31/2024
|
|||
| Janus Henderson Group PLC | 9.9% | ||||
| Janus Henderson Enterprise Fund | 5.0% | ||||
|
Madrigal Pharmaceuticals, Inc.
13G/A
Amendment 4
MDGL · 558868105
|
10.1% |
2/14/2025
Event 12/31/2024
|
|||
|
WEX Inc.
13G/A
Amendment 10
WEX · 96208T104
|
10.2% |
2/14/2025
Event 12/31/2024
|
|||
| Janus Henderson Group PLC | 10.2% | ||||
| Janus Henderson Enterprise Fund | 6.3% | ||||
|
Liberty Media Corporation
13G/A
Amendment 7
FWONK · 531229755
|
6.5% |
2/14/2025
Event 12/31/2024
|
|||
|
Mereo BioPharma Group plc
13G/A
Amendment 3
MREO · 589492107
|
11.0% |
2/14/2025
Event 12/31/2024
|
|||
| Janus Henderson Group PLC | 11.0% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 10.1% | ||||
|
Teleflex Incorporated
13G/A
Amendment 3
TFX · 879369106
|
11.3% |
2/14/2025
Event 12/31/2024
|
|||
| Janus Henderson Group PLC | 11.3% | ||||
| Janus Henderson Enterprise Fund | 6.2% | ||||
|
Soleno Therapeutics, Inc.
13G/A
Amendment 4
SLNO · 834203309
|
12.0% |
2/14/2025
Event 12/31/2024
|
|||
|
Cimpress plc
13G/A
Amendment 11
CMPR · G2143T103
|
12.1% |
2/14/2025
Event 12/31/2024
|
|||
| Janus Henderson Group PLC | 12.1% | ||||
| Janus Henderson Enterprise Fund | 9.4% | ||||
|
Lexeo Therapeutics, Inc.
13G/A
Amendment 3
LXEO · 52886X107
|
13.1% |
2/14/2025
Event 12/31/2024
|
|||
| Janus Henderson Group PLC | 13.1% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 7.6% | ||||
|
Avadel Pharmaceuticals PLC
13G/A
Amendment 3
AVDL · G29687103
|
14.6% |
2/14/2025
Event 12/31/2024
|
|||
| Janus Henderson Group PLC | 14.6% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 5.4% | ||||
|
Ascendis Pharma A/S
13G/A
Amendment 5
ASND · 04351P101
|
7.2% |
2/14/2025
Event 12/31/2024
|
|||
|
Perspective Therapeutics Inc
13G/A
Amendment 1
CATX · 46489V302
|
0% |
2/14/2025
Event 12/31/2024
|
|||
|
Applied Therapeutics Inc
13G/A
Amendment 3
APLT · 03828A101
|
0% |
2/14/2025
Event 12/31/2024
|
|||
|
Pepgen Inc
13G/A
Amendment 1
PEPG · 713317105
|
1.6% |
2/14/2025
Event 12/31/2024
|
|||
|
Immunic, Inc.
13G/A
Amendment 2
IMUX · 4525EP101
|
3.0% |
2/14/2025
Event 12/31/2024
|
|||
|
Caesars Entertainment Inc
13G/A
Amendment 1
CZR · 12769G100
|
3.3% |
2/14/2025
Event 12/31/2024
|
|||
|
Precision BioSciences, Inc.
13G/A
Amendment 2
DTIL · 74019P207
|
0% |
2/14/2025
Event 12/31/2024
|
|||
|
Neogenomics Inc
13G/A
Amendment 1
NEO · 64049M209
|
4.8% |
2/14/2025
Event 12/31/2024
|
|||
|
4D Molecular Therapeutics, Inc.
13G/A
Amendment 4
FDMT · 35104E100
|
4.9% |
2/14/2025
Event 12/31/2024
|
|||
|
Neurogene Inc.
13G/A
Amendment 2
NGNE · 64135M105
|
0% |
2/14/2025
Event 12/31/2024
|
|||
|
CytomX Therapeutics, Inc.
13G/A
Amendment 2
CTMX · 23284F105
|
0% |
2/14/2025
Event 12/31/2024
|
|||
|
Entrada Therapeutics, Inc.
13G
TRDA · 29384C108
|
5.6% |
2/14/2025
Event 12/31/2024
|
|||
| Janus Henderson Group PLC | 5.6% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 5.0% | ||||
|
Forte Biosciences, Inc.
13G
FBRX · 34962G208
|
10.0% |
2/14/2025
Event 12/31/2024
|
|||
| Janus Henderson Group PLC | 10.0% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 10.0% | ||||
|
Revolution Medicines, Inc.
13G
RVMD · 76155X100
|
5.2% |
2/14/2025
Event 12/31/2024
|
|||
|
Edgewise Therapeutics, Inc.
13G
EWTX · 28036F105
|
5.3% |
2/14/2025
Event 12/31/2024
|
|||
|
Avidity Biosciences, Inc.
13G
RNAM · 05370A108
|
5.9% |
2/14/2025
Event 12/31/2024
|
|||
|
Janux Therapeutics, Inc.
13G
JANX · 47103J105
|
6.1% |
2/14/2025
Event 12/31/2024
|
|||
|
Protara Therapeutics, Inc.
13G
TARA · 74365U107
|
6.0% |
2/14/2025
Event 12/31/2024
|
|||
| Janus Henderson Group PLC | 6.6% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 6.0% | ||||
|
Bright Minds Biosciences Inc.
13G
DRUG · 10919W405
|
11.6% |
2/7/2025
Event 1/31/2025
|
|||
| Janus Henderson Group PLC | 11.6% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 10.4% | ||||
|
89bio, Inc.
13G/A
Amendment 5
ETNB · 282559103
|
15.3% |
2/7/2025
Event 1/31/2025
|
|||
| Janus Henderson Group PLC | 15.3% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 5.6% | ||||
|
The Beauty Health Company
13G/A
Amendment 5
SKIN · 88331L108
|
8.8% |
2/7/2025
Event 1/31/2025
|
|||
| Janus Henderson Group PLC | 8.8% | ||||
| Janus Henderson Contrarian Fund | 8.8% | ||||
|
Surgery Partners, Inc.
13G
SGRY · 86881A100
|
9.6% |
1/30/2025
Event 1/29/2025
|
|||
|
Larimar Therapeutics, Inc.
13G/A
Amendment 3
LRMR · 517125100
|
10.1% |
1/8/2025
Event 12/31/2024
|
|||
| Janus Henderson Group PLC | 10.1% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 8.5% | ||||
|
Monopar Therapeutics Inc
13G/A
Amendment 1
MNPR · 61023L207
|
17.2% |
1/8/2025
Event 12/31/2024
|
|||
| Janus Henderson Group PLC | 17.2% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 15.6% | ||||
|
Mereo Biopharma Group PLC
13G/A
Amendment 2
MREO · 589492107
|
10.3% |
12/6/2024
Event 11/29/2024
|
|||
| Janus Henderson Group PLC | 10.3% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 9.3% | ||||
|
Applied Therapeutics Inc
13G/A
Amendment 2
APLT · 03828A101
|
10.4% |
12/6/2024
Event 11/29/2024
|
|||
| Janus Henderson Group PLC | 10.4% | ||||
| Janus Henderson Biotech Innovation Master Fund Ltd | 5.3% | ||||
|
Ardelyx Inc
13G/A
Amendment 4
ARDX · 039697107
|
10.1% |
12/6/2024
Event 11/29/2024
|
|||